EFFECT OF INTRAVENOUS GLIBORNURIDE AND TOLBUTAMIDE ON MYOCARDIAL-CONTRACTILITY

被引：2
作者：
DUBACH, UC
BURCKHARDT, D
RAEDER, EA
FORGO, I
AMREIN, R
BUCKERT, A
机构：
[1] Department of Medicine, Kantonsspital Basel, Basel
来源：
CARDIOLOGY | 1979年 / 64卷 / 04期
关键词：
Glibornuride; Healthy volunteers; I.v; application; Myocardial contractility; Sulplionylureas; Tolbutamide;
D O I：
10.1159/000170617
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The acute effects of therapeutic doses of intravenous tolbutamide and glibornuride on the systolic time intervals (QS2c, LVETC, PEPC and PEP/LVET) were examined in 5 healthy volunteers. Blood sugar was maintained constant throughout the study. No significant changes of these intervals as well as of heart rate and blood pressure were observed. Therefore, it is concluded that tolbutamide and glibornuride have no acute positive inotropic action. © 1979 S. Karger AG, Basel.
引用
收藏
页码：208 / 214
页数：7
相关论文
共 50 条
[31]   Regulation of myocardial contractility by a downstream mechanism [J].
Endoh, M .
CIRCULATION RESEARCH, 1998, 83 (02) :230-232
[32]   A CONTRACTILITY INDEX INDEPENDENT OF MYOCARDIAL LENGTH [J].
TAKEDA, K ;
NAKAMURA, Y ;
KONO, K ;
OGAWA, Y ;
TAKAHASHI, M ;
OYAMA, M ;
MASUDA, T ;
YAGI, S .
JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1992, 56 (07) :722-724
[33]   Regulation of myocardial contractility and cardiac growth [J].
C. Holubarsch ;
Hanjörg Just .
Journal of Molecular Medicine, 1997, 75 :840-841
[34]   Conceptualizing myocardial contractility as an emergent property that characterizes myocardial contraction [J].
Kuang, Serena Y. ;
Geloian, Gorune .
FRONTIERS IN PHYSIOLOGY, 2025, 16
[35]   Modulation of myocardial contractility by lysophosphatidic acid (LPA) [J].
Cremers, B ;
Flesch, M ;
Kostenis, E ;
Maack, C ;
Niedernberg, A ;
Stoff, A ;
Südkamp, M ;
Wendler, O ;
Böhm, M .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2003, 35 (01) :71-80
[36]   PHARMACOKINETICS OF TOLBUTAMIDE FOLLOWING INTRAVENOUS AND ORAL ADMINISTRATIONS IN RATS WITH OBSTRUCTIVE-JAUNDICE [J].
YAMAO, T ;
NAKAGAMI, H ;
FURUHAMA, K ;
ONODERA, T ;
KUROSAKI, Y ;
NAKAYAMA, T ;
KIMURA, T .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 1994, 17 (05) :691-695
[37]   Effect of myocardial contractility on hemodynamic end points under concomitant microvascular disease in a porcine model [J].
Peelukhana, Srikara Viswanath ;
Kolli, Kranthi K. ;
Leesar, Massoud A. ;
Effat, Mohamed A. ;
Helmy, Tarek A. ;
Arif, Imran ;
Schneeberger, Eric W. ;
Succop, Paul ;
Banerjee, Rupak K. .
HEART AND VESSELS, 2014, 29 (01) :97-109
[38]   Effect of myocardial contractility on hemodynamic end points under concomitant microvascular disease in a porcine model [J].
Srikara Viswanath Peelukhana ;
Kranthi K. Kolli ;
Massoud A. Leesar ;
Mohamed A. Effat ;
Tarek A. Helmy ;
Imran Arif ;
Eric W. Schneeberger ;
Paul Succop ;
Rupak K. Banerjee .
Heart and Vessels, 2014, 29 :97-109
[39]   Development of a method for measuring myocardial contractility with gated myocardial SPECT and arterial tonometry [J].
Lee, DS ;
Kim, KM ;
Kim, SK ;
Cheon, GJ ;
Kim, YK ;
Chung, JK ;
Lee, MC .
JOURNAL OF NUCLEAR CARDIOLOGY, 1999, 6 (06) :657-663
[40]   Development of a method for measuring myocardial contractility with gated myocardial SPECT and arterial tonometry [J].
Dong Soo Lee ;
Kyeong Min Kim ;
Seok Ki Kim ;
Gi Jeong Cheon ;
Yoo Kyung Kim ;
June-Key Chung ;
Myung Chul Lee .
Journal of Nuclear Cardiology, 1999, 6 :657-671
12345